Levomac 250 Tablet contains Levofloxacin 250 mg, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of bacterial infections. It exerts its bactericidal action by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. Levomac 250 is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain types of gastroenteritis caused by susceptible strains of bacteria. It is particularly useful in cases where resistance to other antibiotics is a concern. The tablet is administered orally and is well absorbed, achieving therapeutic concentrations in various body tissues and fluids. Dosage should be individualized based on the severity of infection, renal function, and patient-specific factors. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain, as well as central nervous system effects like headache and dizziness. Caution is advised in patients with a history of tendon disorders related to fluoroquinolone use, and it should be avoided in pregnant or lactating women unless clearly indicated. Levomac 250 should be used under medical supervision with adherence to the prescribed course to prevent the development of bacterial resistance.